Search for: "Boehringer Ingelheim Pharmaceutical, Inc" Results 81 - 90 of 90
Sort by Relevance | Sort by Date
RSS Subscribe: 20 results | 100 results
3 Dec 2009, 10:16 pm
Supporters can click the Make it Happen link and send an email to the CEOs of Abbott Laboratories, Boehringer Ingelheim, Bristol-Myers Squibb, Gilead Sciences, GlaxoSmithKline, Johnson & Johnson, Merck & Co, Pfizer Inc. and Sequoia Pharmaceuticals Inc. [read post]
3 Sep 2009, 1:24 am
District Judge Vanessa Bryant ruled on Aug. 27 that Boehringer Ingelheim Pharmaceuticals Inc. violated the Age Discrimination in Employment Act by forcing Robert Raymond, chief patent counsel and vice president for intellectual property, to retire at age 65 in 2004. [read post]
6 Apr 2009, 8:20 am
" Among those companies ordered "to stop using the ads" were "Merck & Co., Roche Holding AG, Bayer AG, Johnson & Johnson, Forest Laboratories Inc., Eli Lilly & Co., Boehringer Ingelheim GmbH, Genentech Inc., GlaxoSmithKline Plc and Novartis AG. [read post]
27 Jun 2008, 6:35 am
Barr Pharmaceuticals Inc. and Mylan Inc. invalidated a patent (4,886,812) of Boehringer Ingelheim on Mirapex in D. [read post]
6 Nov 2007, 5:55 am
Rosenbaum, District of MinnesotaNature of Suits: Consists of 58 actions against Boehringer Ingelheim Pharmaceuticals, Inc. and Pfizer Inc. arising from use of Mirapex, a treatment for Parkinson's disease, which alleged causes obsessive pleasure- and reward-seeking behavior, such as gambling.In re Kugel Mesh Hernia Patch Products Liability Litigation, MDL 1842Filed 2/28/07 and ordered to be transferred on 6/22/2007Transferee Judge and Court: Mary H. [read post]
17 Oct 2007, 8:59 am
  And now the tipping point is in sight as more law departments and law firms inch towards greater use of evaluations and assessments-- and trumpet the benefits.General Counsel Scott Terrillion, of Boehringer Ingelheim Pharmaceuticals Inc, uses an "evaluative selection method" to find the best attorneys for his company, with diversity being a natural consequence. [read post]
26 Apr 2007, 9:28 am
The two big trade mark decisions of the European Court of Justice today have been a little overshadowed by the festivities for World Intellectual Property Day, but the IPKat took just enough time off from his ecstatic celebrations to check the Curia website and see what the ECJ had in store for him.Right: objection to the repackaging of pharma products has led to some grey goods traders taking extreme measures to avoid trade mark infringment litigationCase C-348/04, Boehringer… [read post]
1 Feb 2007, 4:56 pm
The government announced that it was joining a qui tam lawsuit under the False Claims Act against the company Boehringer Ingelheim Roxane, Inc. [read post]
17 Jan 2007, 5:24 am
The companies that have been sued to date are Amgen, Inc.; Astrazeneca Pharmaceuticals, L.P.; Bayer Corp.; Boehringer-Ingelheim Corp.; Eli Lilly, & Co.; GlaxoSmithKline, PLC; Hoffman-LaRoche, Inc.; Johnson & Johnson; Pfizer, Inc.; and Sanofi-Aventis U.S., Inc.Plaintiffs' claim in these cases is that the defendant erroneously classified pharmaceutical sales representatives as exempt from federal or state overtime… [read post]